FDA approves Lorcaserin and Mirabegron extended-release tablets.
Craig I. Coleman, PharmD
Advertisement
Articles by Craig I. Coleman, PharmD
FDA has approved pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.
FDA approves avanafil and tafluprost
FDA approves Lucinactant and Peginesatide
Advertisement
Latest Updated Articles
- Pancrelipase DR caps approved for EPI
August 10th 2012
- New treatments for obesity and OAB
September 15th 2012
- FDA approves oral inhibitor for ED
July 15th 2012
- Lucinactant approved for premie RDS
June 15th 2012
Advertisement
Advertisement
Trending on Drug Topics
1
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
2
Q&A: Pharmacists Can Address ADA Standards Across All Settings
3
Executive Order Calls for Realignment of Childhood Vaccines
4
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
5